Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT02445885

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Led by Thomas Engstrom · Updated on 2026-04-01

150

Participants Needed

1

Research Sites

1243 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Although recommended therapy for patients with ST-segment elevation myocardial infarction is primary PCI, it remains unestablished whether patients with a symptom duration of more 12 hours benefit from acute revascularisation. This study aims to investigate whether acute intervention is superior to subacute intervention in these patients.

CONDITIONS

Official Title

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients more than 18 years of age.
  • ST-segment elevation myocardial infarction (STEMI) with symptom duration greater than 12 hours and less than 36 hours.
  • Clinically stable patients with no ongoing angina, systolic blood pressure greater than 90, and Killip class less than 3.
Not Eligible

You will not qualify if you...

  • Clinical instability requiring an acute invasive strategy.
  • Left main coronary artery occlusion or multivessel disease requiring coronary artery bypass surgery (CABG).
  • Previous Q-wave infarction in the current infarct-related artery.
  • Presence of left bundle branch block (LBBB).
  • Severe kidney (renal) insufficiency.
  • Having a pacemaker.
  • Chronic atrial fibrillation.
  • Previous coronary artery bypass surgery (CABG).
  • Pregnancy.
  • Severe illnesses with life expectancy less than one year.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rigshospitalet

Copenhagen, Capital Region, Denmark, 2100

Actively Recruiting

Loading map...

Research Team

L

Lars Nepper-Christensen, MD

CONTACT

T

Thomas Engstrøm, MDSci, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here